Unveiling Ketamine's Influence on Astrocytic Kir4.1 Channels Through Multimodal Analysis: Confocal Microscopy, Immunocytochemistry, Fluorescence Analysis, and Electrophysiology.
Methods in molecular biology (Clifton, N.J.) – January 01, 2025
Source: PubMed
Summary
Ketamine's rapid antidepressant effects may work through brain cells called astrocytes. New research shows ketamine alters specific potassium channels (Kir4.1) in these cells, affecting how they regulate brain activity. Using advanced imaging and electrical recording techniques, scientists found ketamine changes how these channels move and function, potentially explaining its success in treating major depressive disorder.
Abstract
Understanding the elusive mechanisms responsible for the therapeutic efficacy of ketamine in major depressive disorder (MDD) is crucial. Astrocytes play a vital role in regulating extracellular potassium concentration ([K+]o), which is essential for maintaining proper neuronal excitability and overall brain function. Dysregulation of [K+]o can lead to significant changes in neuronal activity, potentially contributing to the pathophysiology of various neurological and psychiatric conditions, including depression. To this end, we conducted a multifaceted investigation to elucidate the effects of ketamine on the inwardly rectifying K+ channel Kir4.1, which is critical for neuronal excitability and K+ homeostasis. Using cultured rat cortical astrocytes expressing fluorescently labeled Kir4.1 (Kir4.1-EGFP), we followed the dynamics of Kir4.1-EGFP vesicles after ketamine exposure. In addition, using live cell immunolabeling and patch-clamp assays in cultured mouse astrocytes, we investigated the effects of ketamine on Kir4.1 surface density and voltage-activated currents, similar to Ba2+ inhibition. This comprehensive methodological approach sheds light on the modulation of Kir4.1 dynamics by ketamine and thus provides valuable insights into its therapeutic mechanisms in MDD.